Diagnosis and management of pheochromocytoma - Recent advances and current concepts

Kidney International

Volumn 70, Issue SUPPL. 104, 2006, Pages

  Manger, W M ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biochemical testing; Familial genetics; Imaging localization

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 125; (3 IODOBENZYL)GUANIDINE I 131;

CANCER PALLIATIVE THERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAPHY MONITORING; HUMAN; LABORATORY TEST; LAPAROSCOPIC SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REVIEW; TUMOR LOCALIZATION;

EID: 33751072348     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001974     Document Type: Article

References (32)

1. Sutton M, Sheps SG, Lie JL. Prevalence of clinically unsuspected pheochromocytoma: review of a 50-year autopsy series. Mayo Clin Proc 1981; 56: 354-360.
2. Minno AM, Bennett WA, Kvale WF. Pheochromocytoma. A study of 15 cases diagnosed at autopsy. N Engl J Med 1954; 251: 959-965.
3. von Schlegel GG. Neurofibromatose recklinghausen und phä ochromocytom. Schweiz Med Wochenschr 1960; 90: 31-39.
4. McNeil AR, Blok BH, Koelmeyer TD et al. Pheochromocytomas discovered during coronal autopsies in Sydney, Melbourne and Auckland. Aust NZJ Med 2000; 30: 648-652.
5. Whalen RK, Althausen AF, Daniels GH. Extra-adrenal pheochromocytoma. J Urol 1992; 147: 1-10.
6. Manger WM, Gifford Jr RW. Clinical and Experimental Pheochromocytoma. Blackwell Science: Cambridge MA, 1996.
7. Baysal BE, Ferrell RE, Willett-Brozick JE et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000; 287: 848-851.
8. Astuti D, Latif F, Dallod A et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001; 69: 49-54.
9. Pacak K, Lineham WM, Eisenhofer G et al. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001; 135: 315-329.
10. Neumann HP, Bausch B, McWhinney SR et al. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002; 346: 1459-1466.
11. Neuman HPH, Denkel E, Brambs H et al. Pancreatic lesions in the Von Hippel-Lindau syndrome. Gastroenterology 1991; 101: 465-471.
12. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005; 353: 2477-2490.
13. Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J Clin Oncol 2004; 22: 4991-5004.
14. Manger WM, Eisenhofer G. Pheochromocytoma: diagnosis and management update. Curr Hypert Rep 2004; 6: 477-484.
15. Lenders JWM, Pacak K, Walther MM et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002; 287: 1427-1434.
16. Eisenhofer G, Goldstein DS, Walther MM. Biochemical diagnosis of pheochromocytoma: how to distinguish true from false-positive test results. J Clin Endocrinol Metab 2003; 88: 2656-2666.
17. Manger WM. An overview of pheochromocytoma: historical - current concepts - vagaries and diagnostic challenges. N Y Acad Sci 2006; 1073: 1-20.
18. Bergland BE. Pheochromocytoma presenting as shock. Am J Emerg Med 1989; 7: 44-48.
19. Newell KA, Prinz RA, Pickleman J et al. Pheochromocytoma multisystem crisis: a surgical emergency. Arch Surg 1988; 123: 956-959.
20. Jebara VA, Uva MS, Farge A et al. Cardiac pheochromocytomas. Ann Thorac Surg 1992; 53: 356-361.
21. Fink IJ, Reinig JW, Dwyer AJ et al. MR imaging of pheochromocytomas. J Comput Assist Tomogr 1985; 9: 454-458.
22. Baker EM, Spritzer C, Blinder R et al. Benign adrenal lesions mimicking malignancy on MR imaging: report of two cases. Radiology 1987; 163: 669-671.
23. Stowers SA, Gilmore P, Sterling M et al. Cardiac pheochromocytoma involving the left main coronary artery presenting with exertional angina. Am Heart J 1987; 114: 423-427.
24. Sisson JC, Frager MS, Valk TW et al. Scintigraphic localization of pheochromocytoma. N Engl J Med 1981; 305: 12-17.
25. Jalil ND, Pattou FN, Combemale F et al. Effectiveness and limits of preoperative imaging studies for the localizations of pheochromocytomas and paragangliomas: a review of 282 cases. Eur J Surg 1998; 164: 23-28.
26. 111In]-octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab 2001; 86: 685-693.
27. 131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 2003; 88: 4083-4087.
28. Manger WM. Editorial: In search of pheochromocytomas. J Clin Endocrinol Metab 2003; 88: 4080-4082.
29. Mantero F, Massimo T, Arnoldi G et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000; 85: 637-644.
30. 131I-metaiodobenzylguanidine and chemotherapy. Am J Clin Oncol 1999; 22: 364-370.
31. Takahashi K, Ashizawa N, Minami T et al. Malignant pheochromocytoma with multiple hepatic metastases treated by chemotherapy and transcatheter arterial embolization. Intern Med 1999; 38: 349-354.
32. Pacak K, Fojo T, Golstein DS et al. Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytoma. J Natl Cancer Inst 2001; 93: 648-649.